Category - Truvada

#breakthepatent Access AIDS and Knowledge Bayh-Dole Act bio Books Business Centers for Disease Control and Prevention drug pricing Food and Drug Administration Generics Gilead Sciences Government HIV Initiative for Medicines IP News IPWatchdog Articles march-in rights National Institutes of Health orange book Patents pharmaceuticals PhRMA PrEP Technology & Innovation Truvada

Examining the Truvada #BreakThePatent Debate: Gilead Responds

We consider that one of many biggest limitations to Truvada for PrEP entry in the present day is restricted consciousness of Truvada for PrEP’s position in HIV...